Spurney CF, et al
Understanding the specific benefits of the epithalon peptide requires examining the scientific evidence of what the molecule actually does at the cellular level, not just what is claimed in supplement marketing
Is BPC-157 supported by human clinical trials
As research continues to expand understanding of copper peptide mechanisms, clinical applications are likely to evolve and improve
Synapsin LPT Synapsin LPT is a breakthrough nutraceutical developed to support neurological performance, cognitive resilience, and cellular detoxification
For recovery enhancement, performance optimisation, or longevity goals in healthy people, until a randomised, placebo-controlled trial in a defined population with an objective primary endpoint and pharmacovigilance over a clinically meaningful duration produces data we do not currently have, we just don't have good evidence of benefit, let alone safety